QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

NASDAQ:QDEL • US2197981051

22.7 USD
-0.63 (-2.7%)
At close: Feb 26, 2026
22.6 USD
-0.1 (-0.44%)
After Hours: 2/26/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

QDEL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While QDEL is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on QDEL.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • In the past year QDEL had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
  • QDEL had a positive operating cash flow in 4 of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B

1.2 Ratios

  • With a Return On Assets value of -20.78%, QDEL perfoms like the industry average, outperforming 52.43% of the companies in the same industry.
  • QDEL has a Return On Equity of -57.90%. This is comparable to the rest of the industry: QDEL outperforms 48.11% of its industry peers.
  • The Return On Invested Capital of QDEL (1.74%) is better than 67.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for QDEL is significantly below the industry average of 8.75%.
  • The last Return On Invested Capital (1.74%) for QDEL is above the 3 year average (1.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

1.3 Margins

  • QDEL has a better Operating Margin (3.98%) than 67.57% of its industry peers.
  • In the last couple of years the Operating Margin of QDEL has declined.
  • QDEL has a Gross Margin of 47.15%. This is comparable to the rest of the industry: QDEL outperforms 41.62% of its industry peers.
  • QDEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
  • Compared to 1 year ago, QDEL has more shares outstanding
  • The number of shares outstanding for QDEL has been increased compared to 5 years ago.
  • The debt/assets ratio for QDEL is higher compared to a year ago.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • QDEL has an Altman-Z score of 0.71. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of QDEL (0.71) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
  • QDEL has a Debt to Equity ratio of 1.23. This is in the lower half of the industry: QDEL underperforms 77.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACC0.18
WACC9.56%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • QDEL has a Current Ratio of 1.78. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
  • QDEL has a Current ratio of 1.78. This is in the lower half of the industry: QDEL underperforms 67.03% of its industry peers.
  • QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • QDEL's Quick ratio of 0.98 is on the low side compared to the rest of the industry. QDEL is outperformed by 76.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • QDEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.59%, which is quite good.
  • QDEL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.12% yearly.
  • The Revenue has decreased by -1.89% in the past year.
  • Measured over the past years, QDEL shows a quite strong growth in Revenue. The Revenue has been growing by 10.44% on average per year.
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%

3.2 Future

  • Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 23.97% on average per year.
  • Based on estimates for the next years, QDEL will show a small growth in Revenue. The Revenue will grow by 3.63% on average per year.
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.71, the valuation of QDEL can be described as very reasonable.
  • Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.11. QDEL is valued rather cheaply when compared to this.
  • QDEL is valuated reasonably with a Price/Forward Earnings ratio of 8.87.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 96.22% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (28.13), we can say QDEL is valued rather cheaply.
Industry RankSector Rank
PE 10.71
Fwd PE 8.87
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 96.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.51
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • QDEL's earnings are expected to grow with 23.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3Y23.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QUIDELORTHO CORP

NASDAQ:QDEL (2/26/2026, 8:00:00 PM)

After market: 22.6 -0.1 (-0.44%)

22.7

-0.63 (-2.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners123.47%
Inst Owner Change-6.82%
Ins Owners0.61%
Ins Owner Change1.68%
Market Cap1.54B
Revenue(TTM)2.73B
Net Income(TTM)-1.18B
Analysts74.29
Price Target38.18 (68.19%)
Short Float %15.53%
Short Ratio10.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)1.55%
PT rev (3m)-6.82%
EPS NQ rev (1m)0.32%
EPS NQ rev (3m)-44.52%
EPS NY rev (1m)-5.29%
EPS NY rev (3m)-15.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.95%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.71
Fwd PE 8.87
P/S 0.57
P/FCF N/A
P/OCF 41.34
P/B 0.76
P/tB N/A
EV/EBITDA 7.51
EPS(TTM)2.12
EY9.34%
EPS(NY)2.56
Fwd EY11.27%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY2.42%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.52
PEG (5Y)N/A
Graham Number37.81
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-3.3%
ROE(3y)-42.63%
ROE(5y)-16.05%
ROIC(3y)1.38%
ROIC(5y)9.67%
ROICexc(3y)1.42%
ROICexc(5y)14.23%
ROICexgc(3y)4.43%
ROICexgc(5y)27.96%
ROCE(3y)1.75%
ROCE(5y)12.24%
ROICexgc growth 3Y-62.81%
ROICexgc growth 5Y-57.09%
ROICexc growth 3Y-55.09%
ROICexc growth 5Y-58.98%
OM growth 3Y-59.4%
OM growth 5Y-49.97%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.66%
GM growth 5Y-10.48%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.71
F-Score5
WACC9.56%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.59%
EPS 3Y-50.62%
EPS 5Y-36.12%
EPS Q2Q%-26.98%
EPS Next Y20.65%
EPS Next 2Y25.68%
EPS Next 3Y23.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.89%
Revenue growth 3Y-5.8%
Revenue growth 5Y10.44%
Sales Q2Q%2.23%
Revenue Next Year2.46%
Revenue Next 2Y3.26%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y4.34%
EBIT growth 3Y-61.76%
EBIT growth 5Y-44.75%
EBIT Next Year70.26%
EBIT Next 3Y24.99%
EBIT Next 5YN/A
FCF growth 1Y-57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.47%
OCF growth 3YN/A
OCF growth 5YN/A

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 4 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 7 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Undervalued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 4 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 10.71 and the Price/Book (PB) ratio is 0.76.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 20.65% in the next year.